Lysinbio

Developer of antibiotics against drug-resistant infections

placeYuseong District, Hoseo, South Korea calendar_todayFounded 2020 language lysinbio.com

Innovation

5 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 22 times.

YearFilings
20222
20231
20242
20251

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital150%
Other / undisclosed150%
Coming soon